Neuraxis Inc (NRXS)
AMEXHealth CareBiotechnologySnapshot 2026-11-05
$6.11-10.93%
Close 2026-11-05 · 1-day change
AMEXHealth CareBiotechnologySnapshot 2026-11-05
QuarterlyIQ Insights · NRXS
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 9.4% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 117 industry peers
NRXS — dividend update
Dated 2026-10-14
Other Events On October 14, 2026, the Board of Directors of Neuraxis, Inc. (the “ Company ”) authorized and the Company declared a stock dividend on the Company’s Series B Preferred Stock, par value $0.001 per share (the “ Series B Preferred Stock ”) for the third quarter of 2026 (the “ Third Quarter Dividend ”). The Third Quarter Dividend will be paid in the form of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The number of shares of Common Stock to…
Why it matters: Losses grew in Q2 despite management's focus on costs. Q3 results can show whether that trend has turned.
Supportive ifThe November 9 report shows a Q3 operating loss below $2.12 million.
Worry ifThe November 9 report shows a Q3 operating loss above $2.12 million.
Why it matters: Operating losses widened from $1.74 million in Q1 to $2.12 million in Q2. A larger Q3 loss would show further strain.
Worry ifQ3 operating losses are more than $2.12 million.
Less concerning ifQ3 operating losses are $2.12 million or less.
Why it matters: Revenue reached $1.93 million in Q2. A higher Q3 result would extend the growth seen in recent quarters.
Supportive ifQ3 revenue is above $1.93 million.
Worry ifQ3 revenue is below $1.93 million.
Why it matters: The company reported about $7.1 million in cash as of Q1. Cash fell further would raise concern as operations use cash.
Worry ifQ3 cash reserves are below $7.1 million.
Less concerning ifQ3 cash reserves are at or above $7.1 million.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$200 on $10,000 · ±2.0% | How much price usually moves either way. |
| Bad day | $624 loss on $10,000 · 6.2% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,541 loss on $10,000 · 35.4% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.